Back to Trades
Galovan Scott Michael
SVPChief Financial OfficerCIK 0002082926
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Galovan Scott Michael, SVP, Chief Financial Officer, has filed 8 SEC reports (2025–2026), all concentrated in AVANOS MEDICAL, INC. (AVNS), totaling $10.2M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jul 28 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Grant | $7.1M |
| Apr 24 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Tax withheld | $104.2K |
| Apr 1 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Grant | $953.2K |
| Apr 1 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Grant | $959.9K |
| Mar 17 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Grant | $953.2K |
| Mar 11 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Tax withheld | $14.9K |
| Mar 10 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Exercise | $156.7K |
| Aug 22 | AVNS AVANOS MEDICAL, INC. | Galovan Scott Michael | SVP, Chief Financial Officer | Other | $0 |
8 filings